MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 05-23-2026
Burning Rock Biotech Limited EBITDA per Share 2011-2026 | BNR
Annual EBITDA per Share Burning Rock Biotech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -4.62 | -5.86 | -6.11 | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.62 | -6.11 | -5.53 |
Quarterly EBITDA per Share Burning Rock Biotech Limited
| 2025-Q4 | 2024-Q4 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -5.86 | - | - | - | -6.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -5.86 | -6.11 | -5.99 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 201.91 | -0.57 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 88.48 | -0.08 % | $ 4.14 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 3.9 | -9.09 % | $ 5.19 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 20.48 | -1.06 % | $ 594 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 18.53 | -0.8 % | $ 570 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-3.17 | $ 128.84 | -2.11 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.91 | -0.26 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.65 | 3.12 % | $ 7.3 M | USA |
 |
ICON Public Limited Company
ICLR
|
10.5 | $ 146.88 | 0.48 % | $ 11.5 B |  Irlanda |
 |
Illumina
ILMN
|
6.95 | $ 163.68 | 1.68 % | $ 25.4 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.51 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 103.39 | -1.08 % | $ 6.98 B | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 190.49 | 1.59 % | $ 9.44 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 470.34 | 0.64 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 148.0 | 1.46 % | $ 23.7 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.23 | -2.31 % | $ 392 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 11.03 | -1.12 % | $ 1.41 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 18.5 | -1.57 % | $ 414 M | USA |
 |
Natera
NTRA
|
-1.96 | $ 213.73 | 0.78 % | $ 29.2 B | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.35 | 3.05 % | $ 405 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 9.78 | 1.98 % | $ 873 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.75 | 1.1 % | $ 25.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 7.26 | 1.04 % | $ 303 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.03 | -1.22 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 265.4 | -0.29 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 471.72 | 0.61 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.65 | -0.26 % | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 78.53 | 3.09 % | $ 4.7 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.19 | 0.99 % | $ 1.99 B | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |